Kanavos, Panagiotis
Dr Panagiotis Kanavos
|
|
|
|
|
Experience keywords:
international perspective; health related high technology industries; pharmaceuticals; fiscal policy; industrial economics; health economics; health policy; biotechnology; economics; transitional economies; health technology assessment
|
|
|
|
|
|
|
Languages: Spanish [Spoken: Basic, Written: Intermediate]; Greek [Spoken: Fluent, Written: Fluent]; French [Spoken: Intermediate, Written: Fluent]; Romanian [Spoken: Basic, Written: Intermediate]; German [Spoken: Intermediate, Written: Fluent]
|
Media experience:
Radio; TV
|
|
|
|
|
|
The following references are sourced from LSE Research Online|. References that are linked lead to the full text.
Kanavos, Panos and Ferrario, Alessandra and Vandoros, Sotiris and Anderson, Gerard F. (2013) Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health affairs, 32 (4). pp. 753-761. ISSN 0278-2715 Jackson, Timothy L. and Nicod, Elena and Simpson, Andrew and Angelis, Aris and Grimaccia, Federico and Kanavos, Panos (2013) Symptomatic vitreomacular adhesion: a review. Retina, ISSN 1539-2864 Jackson, Timothy L. and Nicod, Elena and Angelis, Aris and Grimaccia, Federico and Prevost, Toby and Simpson, Andrew and Kanavos, Panos (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Retina, ISSN 1539-2864 Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied economics, 45 (22). pp. 3230-3239. ISSN 0003-6846 Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846 Vandoros, Sotiris and Kanavos, Panos (2013) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. The world economy, ISSN 0378-5920 Nicod, Elena and Kanavos, Panos (2012) Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health policy, 108 (2-3). pp. 167-177. ISSN 0168-8510 Kanavos, Panos and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward. Value in health, 15 (8). pp. 1182-1184. ISSN 1098-3015 Linertová, Renata and Serrano-Aguilar, Pedro and Posada-de-la-Paz, Manuel and Hens-Pérez, Manuel and Kanavos, Panos and Taruscio, Domenica and Schieppati, Arrigo and Stefanov, Rumen and Péntek, Márta and Delgado, Claudia and Graf von der Schulenburg, Johann-Matthias and Persson, Ulf and Chevreul, Karine and Fattore, Giovanni and Worbes-Cerezo, Melany and Sefton, Mark and López-Bastida, Julio (2012) Delphi approach to select rare diseases for a European representative survey: the BURQOL-RD study. Health Policy, 108 (1). pp. 19-26. ISSN 0168-8510 Prinja, Shankar and Aggarwal, Arun Kumar and Kumar, Rajesh and Kanavos, Panos (2012) User charges in health care: evidence of effect on service utilization & equity from north India. Indian journal of medical research, supplement , 136 pp. 868-876. ISSN 0367-9012 Prinja, Shankar and Kanavos, Panos and Kumar, Rajesh (2012) Health care inequities in north India: role of public sector in universalizing health care. Indian journal of medical research, 136 pp. 421-431. ISSN 0971-5916 Helfer, Ana Paula and Camargo, Aline Lins and Tavares, Noemia Urruth Leão and Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de salud pública / Pan American journal of public health, 31 (3). pp. 225-232. ISSN 1020-4989 Von der Schulenburg, Fritz and Vandoros, Sotiris and Kanavos, Panos (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health economics review, 1 (1). pp. 1-8. ISSN 2191-1991 Kanavos, Panos G. and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries. Health economics, policy and law, 6 (3). pp. 1-31. ISSN 1744-1331 Sorenson, Corinna and Kanavos, Panos (2011) Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health policy, 100 (1). pp. 43-50. ISSN 0168-8510 Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705 Kanavos, Panos and Vandoros, Sotiris and Irwin, Rachel and Nicod, Elena and Casson, Margaret (2011) Differences in costs of and access to pharmaceutical products in the EU. European Parliament, Brussels Kanavos, Panos and Gemmill-Toyama, Marin (2010) Prescription drug coverage among elderly and disabled Americans: can Medicare—Part D reduce inequities in access? International Journal of Health Care Finance and Economics, 10 (3). pp. 203-218. ISSN 1389-6563 Kanavos, Panos and Vandoros, Sotiris (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and decision economics, 31 (5). pp. 325-338. ISSN 0143-6570 Lluch, Maria and Kanavos, Panos (2010) Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain.. Health policy, 95 (2-3). pp. 245-254. ISSN 0168-8510 Kanavos, Panos and Sullivan, R. and Lewison, G. and Schurer, W. and Eckhouse, S. and Vlachopioti, Z. (2010) The role of funding and policies on innovation in cancer drug development. ecancermedicalscience, 4 ISSN 1754-6605 Kanavos, Panos and Nicod, Elena and Espin, Jaime and van den Aardweg, Stacey (2010) Short- and long-term effects of value-based pricing
vs. external price referencing. EMiNet Kanavos, Panos and Schurer, Willemien (2010) The burden of colorectal cancer: prevention, treatment and quality of services. The European journal of health economics, 10 (Supp.1). pp. 1-3. ISSN 1618-7598 Schurer, Willemien and Kanavos, Panos (2010) Colorectal cancer management in the United Kingdom: current practice and challenges. The European journal of health economics, 10 (Supp.1). pp. 85-90. ISSN 1618-7598 Kanavos, Panos and Nicod, Elena and van den Aardweg, Stacey and Pomedli, Stephen (2010) The impact of health technology assessments: an international comparison. Euro observer, 12 (4). pp. 1-7. ISSN 1020-7481 Kanavos, Panos and Schurer, Willemien (2010) The dynamics of colorectal cancer management in 17 countries. The European journal of health economics, 10 (Supp.1). pp. 115-129. ISSN 1618-7598 Kanavos, Panos and Vandoros, Sotiris and Irwin, Rachel and Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future. European Parliament, Brussels, Belgium Geitona, Mary and Kanavos, Panos (2010) Colocteral cancer management and prevention policies in Greece. The European journal of health economics, 10 (Supp.1). pp. 27-33. ISSN 1618-7598 Kanavos, Panos and Seeley, Elizabeth and Vandoros, Sotiris (2009) Tender systems for outpatient pharmaceuticals in the European Union: evidence from the Netherlands, Germany and Belgium. Enterprise and Industry, European Commission, Brussels, Belgium Sorenson, Corinna and Kanavos, Panos and Karamalis, M. (2009) HTA in Central and Eastern Europe: current status, challenges and opportunities. Journal of medical device regulation, 6 (1). pp. 34-45. ISSN 1759-149X Sorenson, Corinna and Kanavos, Panos (2009) Topic 1: financing medical devices in France and the UK. European Health Technology Institute on Socio-Economic Research Kanavos, Panos and Vandoros, Sotiris and Habicht, Jarno and de Joncheere, Kees (2009) Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy. Regional Office for Europe, World Health Organization, Copenhagen, Denmark Sorenson, Corinna and Drummond, Michael and Kanavos, Panos and McGuire, Alistair (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? ISPOR connections, 14 (4). pp. 7-9. ISSN 1538-5108 Kanavos, Panos and Schurer, Willemien and Owusu-Apenten, Candida and Sullivan, Richard (2008) Colorectal cancer in Europe and Australia: challenges and opportunities for the future. LSE Health, London School of Economics and Political Science, London, UK Sorenson, Corinna and Drummond, Michael and Kanavos, Panos and McGuire, Alistair (2008) National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? National Pharmaceutical Council, Virginia, USA Sorenson, Corinna and Drummond, Michael and Kanavos, Panos (2008) Ensuring value for money in health care: the role of health technology assessment in the European Union. World Health Organization Regional Office for Europe, Copenhagen, Denmark. ISBN 9789289071833 McGuire, Alistair and Raikou, Maria and Kanavos, Panos (2008) Pricing pharmaceuticals: value based pricing in what sense? Eurohealth, 14 (2). pp. 3-6. ISSN 1356-1030 Kanavos, Panos and Vandoros, Sotiris (2008) Validation of the Russian federal prescribing database and evaluation of policy outcomes. Russian Federal Bureau of Obligatory Medical Insurance Kanavos, Panos and Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic policy, 23 (55). pp. 499-544. ISSN 0266-4658 Sorenson, Corinna and Drummond, Michael and Kanavos, Panos (2007) Ensuring value for money in health care: The role of HTA in the European Union. In:Financing sustainable healthcare in Europe: New approaches for new outcomes (7-8 February 2007 : Helsinki, Finland). Kanavos, Panos (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, vol. 23(1).. Current medical research and opinion, 23 (1). pp. 105-116. ISSN 0300-7995 Costa-i-Font, Joan and Kanavos, Panos and Rovira-Forns, Joan (2007) Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia. Applied economics, 39 (5). pp. 541-551. ISSN 0003-6846 Kanavos, Panos and Costa-i-Font, Joan and McGuire, Alistair (2007) Product differentiation, competition and regulation of new drugs: the case of statins in four European countries. Managerial and decision economics, 28 (4-5). pp. 455-465. ISSN 1099-1468 Costa-i-Font, Joan and Kanavos, Panos (2007) Importaciones paralelas de medicamentos: El caso de la Simvastaina en Alemania, Holanda y el Reino Unido. Gaceta sanitaria, 21 (1). pp. 53-59. ISSN 0213-9111 Gemmill, Marin and Costa-i-Font, Joan and Kanavos, Panos (2006) Insurance coverage and the heterogeneity of health and drug spending in the United States. Geneva papers on risk and insurance, 31 (4). pp. 669-691. ISSN 1018-5895 Kanavos, Panos and Saka, R (2006) Economic evaluation for orphan drugs: is it possible? Eurohealth, ISSN 1356-1030 Hockley, Tony and Kanavos, Panos and Rudisill, Caroline (2006) The IFPMA Health Partnerships Survey: a critical appraisal. London School of Economics and Political Science, London, UK Kanavos, Panos (2006) The rising burden of cancer in the developing world. Annals of oncology, 17 (Supple). ISSN 0923-7534 Kanavos, Panos and Yfantopoulos, J. and Politis, C. and Vandoros, C. (2006) The economics of blood: gift of life or a commodity? International journal of technology assessment in health care, 22 (3). pp. 338-343. ISSN 0266-4623 Morgan, S and McMahon, M and Mitton, C and Rougehead, E and Kirk, R and Kanavos, Panos and Menom, D (2006) Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health affairs, 25 (2). pp. 337-347. ISSN 0278-2715 Tatar, Mehtap and Kanavos, Panos (2006) Health care reform in Turkey: a dynamic path in the wake of political consensus. Eurohealth, 12 (1). pp. 20-22. ISSN 1356-1030 Kanavos, Panos and Ustel, I. and Tatar, M. and Costa-i-Font, Joan (2006) Health and drug sector reform in Turkey: caveats and opportunities. Health and Social Care, London School of Economics and Political Science, London, UK Kanavos, Panos and Costa-i-Font, Joan (2005) Pharmaceutical parallel trade in Europe: stakeholders and competition effects. Economic policy, 20 (44). pp. 751-798. ISSN 0266-4658 Park, Sylvia and Ross-Degnan, Dennis and Adams, Alyce S and Sabin, James and Kanavos, Panagiotis and Soumerai, Stephen B (2005) Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: a population-based study. British journal of psychiatry, 187 (2). pp. 137-142. ISSN 0007-1250 Kanavos, Panos and Gross, David and Taylor, David (2005) Parallel trading in medicines: Europe’s experience and its implications for commercial drug importation in the United States. American Association for Retired Persons, Washington, DC., USA Kanavos, Panos and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease management and health outcomes, 13 (6). pp. 359-370. ISSN 1173-8790 Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip, London. Kanavos, Panos and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS. Disease management and health outcomes, 13 (6). pp. 359-370. ISSN 1173-8790 Costa-i-Font, Joan and Kanavos, Panos (2005) Efectos del comercio paralelo de medicamentos en la Unión Europea y evidencia de Alemania. Boletin de estudios economicos, 60 (185). pp. 251-263. ISSN 0006-6249 Kanavos, Panos and Holmes, P and Loudon, David and Benedict, Irvine (2005) Pharmaceutical parallel trade in the UK. CIVITAS, London, UK. ISBN 9781903386392 Knapp, Martin and Kanavos, Panos and King, Derek and Yesudian, Hannah Monica (2005) Economic issues in access to medications: Schizophrenia treatment in England. International journal of law and psychiatry, 28 (5). pp. 514-531. ISSN 0160-2527 Kanavos, Panos and Costa-i-Font, Joan and Merkur, S. and Gemmill, M. (2004) The economic impact of pharmaceutical parallel trade in European union member states: a stakeholder analysis. London School of Economics and Political Science, London, UK Kanavos, Panagiotis and Tatar, D and Taylor, D (2004) Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos, Elias and Mrazek, M and Walley, T, (eds.) Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality. Open University Press, Maidenhead, UK, pp. 196-212. ISBN 0335214657 Kanavos, Panos and Gemmill, M (2004) Senior citizens and the burden of prescription drug outlays: what lessons for the Medicare prescription drug benefit? Applied health economics and health policy, 3 (4). pp. 217-227. ISSN 1175-5652 Kanavos, Panos and Soumerai, Stephen B and Ross-Degnan, Dennis (2004) Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector. In: Mossialos, Elias and Mrazek, Monique F. and Walley, Tom, (eds.) Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press on behalf of the European Observatory on Health Systems and Policies, Maidenhead, UK, pp. 97-113. ISBN 9780335214655 Kanavos, Panos and Holmes, P. R. (2004) Financial flows to global health partnerships. Department for International Development, London, UK Kanavos, Panos (2003) Reference pricing for drugs: is it compatible with US healthcare? Health Affairs, 22 (3). pp. 16-30. ISSN 0278-2715 Kanavos, Panos and Mossialos, Elias (2003) Managing healthcare reform: evaluation of available options. In: Stoddart, G and Zollner, H and Selby-Smith, C, (eds.) Learning to live with healthcare reform. World Health Organization Regional Office for Europe, Copenhagan, Denmark. Kanavos, Panos (2003) Implications of financing systems. In: Zollner, H and Stoddart, G and Selby Smith, C, (eds.) Learning to live with health economics. World Health Organization for Europe, pp. 69-86. Kanavos, Panos (2002) Pharmaceutical regulation in Europe. In:Institute for Research on Public Policy Conference – Toward a National Strategy on Drug Insurance: Challenges and Priorities (September 23 2002 : Toronto, Ontario). King, Derek R. and Kanavos, Panos (2002) Encouraging the use of generic medicines: implications for transition economies. Croatian medical journal, 43 (4). pp. 462-469. ISSN 0353-9504 Kanavos, Panos and Lim, J Y and Pascual, C S (2002) On improving accessibility of drugs for the poor. The World Bank Kanavos, Panos (2002) EU pharmaceutical policy: the challenges and opportunities of enlargement. Eurohealth, 8 (4). pp. 24-26. ISSN 1356-1030 Kanavos, Panos and Lim, J Y and Pascual, C S (2002) On improving the poor's access to affordable drugs. The World Bank Kanavos, Panos and Mossialos, Elias (2002) Evaluation of health care reform options. In: Zollner, H and Stoddart, G and Selby Smith, C, (eds.) Learning to live with health economics. World Health Economics for Europe, pp. 37-48. Kanavos, Panos (2001) Overview of pharmaceutical pricing and reimbursement regulation. LSE Health, London, U.K. Kanavos, Panos and Trueman, P and Bosilevac, A (2000) Can economic evaluation guidelines improve efficiency in resource allocation? International journal of technology assessment in health care, 16 (4). pp. 1179-1192. ISSN 0266-4623 Kanavos, Panos and McKee, Martin (2000) Cross-border issues in the provision of health services: are we moving towards a European health policy? Journal of health services research & policy, 5 (4). pp. 231-236. ISSN 1355-8196 Maynard, Alan and Kanavos, Panos (2000) Health economics: an evolving paradigm. Health economics, 9 (3). pp. 183-190. ISSN 1057-9230 Kanavos, Panos (2000) Towards evidence-based decisions in health care: a prospective assessment of training needs in health economics and management in the European Union. Hepac (Health Economics in Prevention and Care), 1 (1). pp. 78-90. ISSN 1439-3972 Kanavos, Panos (2000) The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings. Pharmacoeconomics, 18 (6). pp. 523-532. ISSN 1170-7690 Trueman, P. and Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 2: 'the fourth hurdle': what does it mean for drug development? Clinical research focus, 11 (2). pp. 24-29. ISSN 0968-0594 Trueman, P. and Kanavos, Panos and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 1: guidelines for economic evaluation and their role in health policy. Clinical research focus, 11 (1). pp. 23-29. ISSN 0968-0594 Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian medical journal, 40 (June). pp. 244-259. ISSN 0353-9504 Kanavos, Panos and Mossialos, Elias (1999) Outstanding regulatory issues in the European Union pharmaceutical market. Pharmacoeconomics, 15 (6). pp. 519-533. ISSN 1170-7690
LSE Research Online is the primary resource for references to publications. For queries or updates please email the LSE Research Online team at lseresearchonline@lse.ac.uk|.
|
|
|
|
Browse the Experts Directory:
|
Collection of LSE research outputs
Service providing unique access
to LSE's expertise
[access restricted to staff]
Short articles about LSE research
|